Welcome to this video featuring Baroness Greenfield, who delves into the remarkable progress in Alzheimer’s research over the past fifty years. In this enlightening talk, she explores the increasing personal impact of the disease, highlighting the disturbing rise in cases, especially within our aging population. Baroness Greenfield underscores the urgent need for an affordable, globally accessible, and accurate diagnostic test to detect Alzheimer’s before early symptoms manifest, which is vital for combating this neurodegenerative disorder. She also discusses the link between elevated T14 levels and cognitive decline, proposing that maintaining a controlled balance of T14, which varies with age and individuals, could be the key to curing this devastating disease. Join us to gain valuable insights from one of the leading voices in neuroscience.
LATEST NEWS
- CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
- Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!
- Our CSO Sara Garcia Rates & Project Development Manager, Bethany Watkinson, will be attending the MediWales (BioWales) event on Thursday 5th February
- Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield is attending the “Inspire and Innovate with wise+ (Women in Innovation, Science & Engineering)” at the Novartis Basel Campus
- Neuro-bio hosts the Tenants lunch for Culham Campus!